Nano-crystalline Megestrol Acetate Oral Suspension
Sponsors
Changchun GeneScience Pharmaceutical Co., Ltd., Guangzhou Institute of Respiratory Disease
Conditions
CachexiaCachexia-Anorexia SyndromeCancer-related Fatigue， Gastric Cancer，Colorectal Cancer，Nano-crystalline Megestrol Acetate，Megestrol Acetate，First-line TreatmentColorectal CancerDigestive System CancerExtensive-stage Small Cell Lung Cancer (ES-SCLC)Gastric CancerHead and Neck Squamous Cell Carcinoma; Underwent Surgery Within 6 Weeks and Postoperative Assessment Indicated High-risk Factors
Phase 2
Phase 3
Nano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck Squamous Cell Carcinoma After Surgery.
Not yet recruitingNCT06772428
Start: 2025-01-01End: 2027-12-31Target: 96Updated: 2025-01-13
Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase
Not yet recruitingNCT06961201
Start: 2025-05-01End: 2027-06-30Target: 94Updated: 2025-05-07
Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis
Not yet recruitingNCT06961188
Start: 2025-06-01End: 2027-12-31Target: 174Updated: 2025-05-07
Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
RecruitingNCT07150663
Start: 2025-08-20End: 2027-12-31Target: 134Updated: 2025-09-08
Unknown Phase
Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related Fatigue
RecruitingNCT06830018
Start: 2025-01-23End: 2026-07-31Target: 76Updated: 2025-02-17
Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors
RecruitingNCT06940102
Start: 2025-03-12End: 2026-12-31Target: 120Updated: 2025-04-23